Evaluation of a Recombinant Rift Valley Fever Virus Subunit Nucleocapsid Protein as an Immunogen in Mice and Sheep

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The Open Vaccine Journal

• Publication date

  2010-04-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1875035401003010114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sentinel Surveillance of Influenza-Like-Illness in Two Cities of the Tropical Country of Ecuador: 2006–2010

  2011cited by this paper
• Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.

  2009cited by this paper
• A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge

  2009cited by this paper
• Development and Evaluation of a Real-Time Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Rift Valley Fever Virus in Clinical Specimens

  2009cited by this paper
• Laboratory safe detection of nucleocapsid protein of Rift Valley fever virus in human and animal specimens by a sandwich ELISA.

  2009cited by this paper
• An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus

  2009cited by this paper
• Truncated Recombinant Puumala Virus Nucleocapsid Proteins Protect Mice Against Challenge in Vivo

  2008cited by this paper
• Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo.

  2008cited by this paper
• Vector Competence of Selected African Mosquito (Diptera: Culicidae) Species for Rift Valley Fever Virus

  2008cited by this paper
• Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.

  2008cited by this paper
• Vaccination of BALB/c Mice with Escherichia coli-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge

  2008cited by this paper
• Rift Valley Fever Virus Lacking the NSs and NSm Genes Is Highly Attenuated, Confers Protective Immunity from Virulent Virus Challenge, and Allows for Differential Identification of Infected and Vaccinated Animals

  2008cited by this paper
• Potential for North American Mosquitoes to Transmit Rift Valley Fever Virus1

  2008cited by this paper
• VECTOR COMPETENCE OF KENYAN CULEX ZOMBAENSIS AND CULEX QUINQUEFASCIATUS MOSQUITOES FOR RIFT VALLEY FEVER VIRUS1

  2007cited by this paper
• Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA.

  2007cited by this paper
• Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans.

  2007cited by this paper
• Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife

  2007cited by this paper
• Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae).

  2007cited by this paper
• Rift Valley fever outbreak--Kenya, November 2006-January 2007.

  2007cited by this paper
• Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants.

  2007cited by this paper
• Truncated Recombinant Dobrava Hantavirus Nucleocapsid Proteins Induce Strong, Long-Lasting Immune Responses in Mice

  2006cited by this paper
• Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus.

  2006cited by this paper
• Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.

  2006cited by this paper
• Immune responses to recombinants of the South African vaccine strain of lumpy skin disease virus generated by using thymidine kinase gene insertion.

  2005cited by this paper
• Rift Valley fever.

  2004cited by this paper
• Current vaccine adjuvants: an overview of a diverse class.

  2004cited by this paper
• Targeting TFIIH to inhibit host cell transcription by Rift Valley Fever Virus.

  2004cited by this paper
• IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants.

  2003cited by this paper
• Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

  2003cited by this paper
• A critical role for NF-kappaB transcription factors in the development of CD8+ memory-phenotype T cells.

  2003cited by this paper
• Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep.

  2002cited by this paper
• An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98

  2002cited by this paper
• The Common Vaccine Adjuvant Aluminum Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an Interleukin-4-Dependent Mechanism

  2001cited by this paper
• Recent developments in adjuvants for vaccines against infectious diseases.

  2001cited by this paper
• NF-κB Is Required for the Positive Selection of CD8+ Thymocytes1

  2000cited by this paper
• Humoral Response in Toscana Virus Acute Neurologic Disease Investigated by Viral-Protein-Specific Immunoassays

  1999cited by this paper
• Advances in vaccine adjuvants

  1999cited by this paper
• Rift Valley fever outbreak in Kenya

  1998cited by this paper
• J. Virol. Methods

  1996cited by this paper
• Imported vector- and rodent-borne virus infections--an introduction.

  1996cited by this paper
• Saponins as vaccine adjuvants.

  1996cited by this paper
• Human B‐cell epitopes of puumala virus nucleocapsid protein, the major antigen in early serological response

  1995cited by this paper
• Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.

  1995cited by this paper
• Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses.

  1991cited by this paper
• Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants

  1990cited by this paper
• Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins.

  1989cited by this paper
• Vector potential of selected North American mosquito species for Rift Valley fever virus.

  1988cited by this paper
• Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep

  1986cited by this paper
• Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation.

  1985cited by this paper
• Protective subunit immunogens to rift valley fever virus from bacteria and recombinant vaccinia virus

  1985cited by this paper
• Novel coding strategy (ambisense genomic RNA) revealed by sequence analyses of Punta Toro Phlebovirus S RNA.

  1984cited by this paper
• Rift valley fever

  1982cited by this paper
• Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.

  1979cited by this paper
• Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche

  1931cited by this paper

• A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice

  2018cites this paper
• Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.

  2016cites this paper
• Multiplex Detection of IgG and IgM to Rift Valley Fever Virus Nucleoprotein, Nonstructural Proteins, and Glycoprotein in Ovine and Bovine

  2016cites this paper
• Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease

  2015cites this paper
• The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8+ T Cell Antigen and Elicits Memory Responses

  2013cites this paper
• RIFT VALLEY FEVER VIRUS VACCINE STRATEGIES

  2013cites this paper
• Rift Valley Fever Virus Structural and Nonstructural Proteins: Recombinant Protein Expression and Immunoreactivity Against Antisera from Sheep

  2013cites this paper
• MBT/Pas mouse: a relevant model for the evaluation of Rift Valley fever vaccines.

  2012cites this paper
• Anti-Nucleocapsid Protein Immune Responses Counteract Pathogenic Effects of Rift Valley Fever Virus Infection in Mice

  2011cites this paper
• TerraSAR-X high-resolution radar remote sensing: an operational warning system for Rift Valley fever risk.

  2010cites this paper